The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Eric Nelius und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Natural Cytotoxicity Triggering Receptor 1, Colitis, Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Swiss Cancer Research Foundation.
Abstract (Originalsprache)
Innate lymphoid cells (ILCs) are critical for intestinal adaptation to microenvironmental challenges, and the gut mucosa is characterized by low oxygen. Adaptation to low oxygen is mediated by hypoxia-inducible transcription factors (HIFs), and the HIF-1α subunit shapes an ILC phenotype upon acute colitis that contributes to intestinal damage. However, the impact of HIF signaling in NKp46 + ILCs in the context of repetitive mucosal damage and chronic inflammation, as it typically occurs during inflammatory bowel disease, is unknown. In chronic colitis, mice lacking the HIF-1α isoform in NKp46+ ILCs show a decrease in NKp46 + ILC1s but a concomitant rise in neutrophils and Ly6C high macrophages. Single-nucleus RNA sequencing suggests enhanced interaction of mesenchymal cells with other cell compartments in the colon of HIF-1α KO mice and a loss of mucus-producing enterocytes and intestinal stem cells. This was, furthermore, associated with increased bone morphogenetic pathway–integrin signaling, expansion of fibroblast subsets, and intestinal fibrosis. In summary, this suggests that HIF-1α–mediated ILC1 activation, although detrimental upon acute colitis, protects against excessive inflammation and fibrosis during chronic intestinal damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Anatomy, University of Zurich, Zurich, Switzerland.
- Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
- Division of Cardiology and Metabolism, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
- University of Innsbruck, Innsbruck, Austria.
- Institute of Anatomy, University of Zurich, Zurich, Switzerland christian.stockmann@anatomy.uzh.ch.
- Comprehensive Cancer Center Zurich, Zurich, Switzerland.
ORCID-Profile: Eric Nelius, Dagmar Gotthardt, Christian Stockmann
Förderung
- SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Swiss Cancer Research Foundation
Zitieren
APA
Nelius, E., Fan, Z., Sobecki, M., Krzywinska, E., Nagarajan, S., Ferapontova, I., Gotthardt, D., Takeda, N., Sexl, V., & Stockmann, C. (2024). The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis. Life Science Alliance. https://doi.org/10.26508/lsa.202402593
Vancouver
Nelius E, Fan Z, Sobecki M, Krzywinska E, Nagarajan S, Ferapontova I, et al. The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis. Life Science Alliance. 2024. doi:10.26508/lsa.202402593
BibTeX
@article{Nelius2024,
author = {Nelius, Eric and Fan, Zheng and Sobecki, Michal and Krzywinska, Ewelina and Nagarajan, Shunmugam and Ferapontova, Irina and Gotthardt, Dagmar and Takeda, Norihiko and Sexl, Veronika and Stockmann, Christian},
title = {The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402593}
}
EUVIMED